Jazz Pharmaceuticals Plc
(NASDAQ : JAZZ)

( )
JAZZ After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
4.02%16.051.8%$144.15m
VRXValeant Pharmaceuticals International, Inc.
5.39%22.4114.1%$131.86m
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.33%152.866.2%$80.43m
PRGOPerrigo Co. Plc
1.70%47.936.8%$72.29m
SAGESAGE Therapeutics, Inc.
1.92%167.848.6%$65.10m
JAZZJazz Pharmaceuticals Plc
-1.91%133.852.3%$53.73m
HZNPHorizon Pharma plc
1.38%27.976.7%$44.81m
PTLAPortola Pharmaceuticals, Inc.
0.04%28.907.5%$41.78m
UTHRUnited Therapeutics Corporation
1.81%82.7814.3%$41.68m
ICLRICON Plc
-0.73%155.574.1%$38.02m
MDCOMedicines Company
4.48%34.3020.3%$36.84m
CTLTCatalent Inc
-0.11%55.712.4%$36.41m
ICPTIntercept Pharmaceuticals, Inc.
2.43%67.4617.2%$36.26m
AERIAerie Pharmaceuticals, Inc.
8.22%24.356.8%$25.46m
PCRXPacira Pharmaceuticals, Inc.
3.77%39.3810.5%$25.11m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Dublin, Ireland.